在B细胞和T细胞淋巴瘤中的表观遗传点:最新进展
Marcelo Lima Ribeiro1,2, Salvador Sánchez Vinces2, Laura Mondragon3
1Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
Therapeutic advances in hematology
|June 5, 2023
概括
在非霍奇金淋巴瘤 (NHLs) 中,表观遗传失调是常见的. 用新药向这些表观遗传改变为复发或耐药病例提供了有希望的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 血液学 血液学 血液学
背景情况:
- 非霍奇金淋巴瘤 (NHLs) 是各种各样的淋巴细胞恶性瘤,具有不同的分子和临床特征.
- 虽然许多NHL对常规治疗有反应,但复发/耐药病例的结果很差.
- 表观遗传失调,包括表观遗传酶突变,在B细胞和T细胞淋巴瘤中普遍存在.
研究的目的:
- 总结B细胞和T细胞NHL的关键表观遗传变化.
- 审查针对NHLs的表观遗传修饰剂 (表观药物) 的开发和临床应用.
- 探索未来的研究方向和生物信息学在识别新表观遗传标中的作用.
主要方法:
- 关于NHLs表观遗传变化的科学文献的综述.
- 对已批准和正在研究的流行病药物进行临床试验数据的分析.
- 讨论生物信息学方法用于目标发现.
主要成果:
- 在NHL中经常观察到表观遗传变化,影响染色质修饰剂和DNA甲基转移酶 (DNMTs).
- 包括DNMT,基因组脱乙酶 (HDAC) 和原蛋白和额外终端动机 (BET) 抑制剂在内的几类抗肺炎药物正在临床研究或获得批准.
- 这些药物在治疗特定的NHL亚型方面表现出潜力.
结论:
- 表观遗传修饰是NHL治疗干预的关键领域.
- 以深度测序和生物信息学为基础的向表观遗传疗法,有望改善复发性/耐药性NHL的治疗结果.
- 需要进一步的研究,以充分阐明表观遗传学的作用,并优化抗疫药物策略.
关键词:
BET 抑制剂是 BET 抑制剂.在DNMT中使用DNMT.在 EZH2 中使用.帽子 帽子 帽子在HDAC的基础上,HDAC是生物信息学是一种生物信息学.临床试验 临床试验是指临床试验.药物组合是药物组合.表观遗传学是指表观遗传学.其他非霍奇金淋巴瘤.更多相关视频
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.6K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
01:24B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K